Ocular Therapeutix, Inc.
OCUL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$193,506 | -$80,736 | -$71,038 | -$6,553 |
| Dep. & Amort. | $3,786 | $2,983 | $2,109 | $2,421 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $33,109 | $17,825 | $16,964 | $14,977 |
| Change in WC | -$10,230 | -$7,411 | $1,349 | -$2,901 |
| Other Non-Cash | $32,164 | -$2,895 | -$8,987 | -$73,494 |
| Operating Cash Flow | -$134,677 | -$70,234 | -$59,603 | -$65,550 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,288 | -$6,087 | -$3,715 | -$1,194 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1,288 | -$6,087 | -$3,715 | -$1,194 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $316,353 | $56,349 | $0 | -$445 |
| Stock Issued | $316,353 | $118,112 | $940 | $985 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$300,596 | -$4,633 | $514 | $2,311 |
| Financing Cash Flow | $332,110 | $169,828 | $1,454 | $2,851 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $196,145 | $93,507 | -$61,864 | -$63,893 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $197,571 | $104,064 | $165,928 | $229,821 |
| End Cash | $393,716 | $197,571 | $104,064 | $165,928 |
| Free Cash Flow | -$135,965 | -$76,321 | -$63,318 | -$66,744 |